The firm’s Corporate Finance team has advised Nodus, founded by Cumulus Oncology and in partnership with the Lead Discovery Center Burges Salmon’s Corporate Finance team has advised biotech company Nodus Oncology, a novel biotech company, on its strategic acquisition of certain oncology based IP assets...

Burges Salmon has advised voice-based, AI-driven, digital health platform Albert Health on landmark seed round investment of $1 million. It was led by Sabanci Ventures, with participation from Teknoloji Yatirim A.S., AK Portföy and EGİAD Melekleri. Albert Health enables patients to manage their chronic conditions....

Cytomos, an Edinburgh-based life science company, has secured funding to progress its novel cell analysis platform Burges Salmon has advised Cytomos Limited on its £1.6 million funding from a trio of investors to progress the development and qualification of its novel cell analysis platform, Cytomos...